OFS Capital (OFS) Earnings Analysis
OFS Capital (OFS) next reports earnings on 2026-07-30, consensus EPS 0.14 USD. Last quarter (2026-04-30) it missed with EPS 0.18 USD vs 0.21 USD est (-14.3%). It has beaten estimates in 3/8 recent quarters (38%). Trailing P/E -1.24.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OFS next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | 0.14 USD |
| Revenue estimate | 0.01B |
OFS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | 0.18 USD | 0.21 USD | -14.3% | Miss |
| 2026-03-02 | 0.2 USD | 0.32 USD | -37.5% | Miss |
| 2025-10-30 | 0.22 USD | 0.24 USD | -8.3% | Miss |
| 2025-07-31 | 0.25 USD | 0.24 USD | +4.2% | Beat |
| 2025-05-01 | 0.26 USD | 0.33 USD | -21.2% | Miss |
| 2025-03-03 | 0.3 USD | 0.25 USD | +20% | Beat |
| 2024-10-31 | 0.27 USD | 0.25 USD | +8% | Beat |
| 2024-08-01 | 0.26 USD | 0.29 USD | -10.3% | Miss |
Beat rate: 3/8 (38%) over reported quarters with consensus data.
OFS valuation and analyst view
| Trailing P/E | -1.24 |
|---|---|
| Trailing EPS | -2.791 USD |
| Price / book | 0.42 |
| Dividend yield | 24.57% |
| Market cap | 0.05B |
| Analyst consensus | Buy (4 buy / 2 hold / 1 sell) |
| Avg price target | 7 USD |
Related research pages
Frequently asked questions
When is OFS Capital (OFS)'s next earnings date?
OFS Capital is next scheduled to report on 2026-07-30, with a consensus EPS estimate of 0.14 USD and revenue estimate of 0.01B.
Did OFS beat earnings last quarter?
In its 2026-04-30 report, OFS posted EPS of 0.18 USD versus a 0.21 USD estimate — a miss of 14.3%.
What is OFS's earnings track record?
Over the last 8 reported quarters with consensus data, OFS beat estimates 3 times (38%).
What is OFS's current P/E ratio and EPS?
OFS trades at a trailing P/E of -1.24 on trailing EPS of -2.790997335587985 USD.
What do analysts rate OFS?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 4 buy, 2 hold, 1 sell, 0 strong sell). Average 12-month price target: 7 USD.